Fugen Aker Vardar

Benefits of Neoadjuvant Chemotherapy for Luminal Breast Cancer with Respect to Tumor Response

Bala Başak Öven, Serkan Çelik, Günay Gürleyik, Fugen Aker Vardar et autres

ABS TRACT Objective:The pathological complete response (PCR) rate following neoadjuvant chemotherapy (NAC) is prognostic for overall survival (OS).We evaluated the pathological responses to NAC and related factors in luminal type HER2-positive breast cancer.Materials and Methods: Hormone receptor (H), HER2/neu status, and Ki67 …

tr (code pays fourni par la source)

The relationship between positron emission tomography-computed tomography imaging and histopathological features of thyroid incidentalomas detected during follow-up for primary malignancy

Bala Başak Öven, Ahmet Erkan Bilici, Mehmet Tarık Tatoğlu, Şule Canberk et autres

AIM OF THE STUDY: ) value and PET imaging features. MATERIALS AND METHODS: . RESULTS: (r = 0.318, P = 0.04) and negatively correlated with both the density of the thyroid nodule in PET-CT (r = -0.0042, P = 0.01) and density …

tr (code pays fourni par la source)

Clinical importance of discordance of hormone receptors and Her2/neu status after neoadjuvant chemotherapy in breast cancer.

Bala Başak Öven Ustaalıoğlu, Fugen Aker Vardar, Ahmet Erkan Bilici, Günay Gürleyik et autres

PURPOSE: The aim of this study was to compare the hormone receptors' (HR) and HER2/neu status between core needle biopsy (CNB) and residual tumor after surgery of breast cancer treated with neoadjuvant chemotherapy (NAC), and also to evaluate the impact of discordance …

tr (code pays fourni par la source)

Is it Possible to Avoid Unnecessary FNAs with the Use of TIRADS (Thyroid Imaging Reporting and Data System) and Elastogram? A Comparison Study with the 6-tiered (Bethesda System for Reporting Thyroid Cytology - “TBSRTC”) and 5-tiered (British Thyroid Association-Royal College of Physicians - “BTA/RCP” and Italian Society for Anatomic Pathology and Cytopathology - “SIAPEC”) FNA Classification Systems

Şule Canberk, Tugba Atasoy, Gamze Z. Kilicoglu, Fugen Aker Vardar et autres

tr (code pays fourni par la source)

Important Factors Affecting Adjuvant Treatment Decision in Stage IA Breast Cancer Patients in Turkey

Bala Başak Öven Ustaalıoğlu, Ahmet Erkan Bilici, Burcak Erkol Yılmaz, Mehmet Aliustaoğlu et autres

INTRODUCTION: In Turkey, the gene expression profile test is not standard, so adjuvant treatment is planned according to clinicopathological factors. Therefore, we retrospectively analyzed important parameters that affect the decision on adjuvant chemotherapy, and also factors related to survival in stage IA …

tr (code pays fourni par la source)

Contents of Forthcoming Issues

Toralf Reimer, Steffi Hartmann, Angrit Stachs, Bernd Gerber et autres

Reports of Oncological Societies

Toralf Reimer, Steffi Hartmann, Angrit Stachs, Bernd Gerber et autres

PharmaNews / PharmaTicker

Toralf Reimer, Steffi Hartmann, Angrit Stachs, Bernd Gerber et autres

Die Deutsche Krebsgesellschaft e

Editorial Board / Contents / Guidelines

Toralf Reimer, Steffi Hartmann, Angrit Stachs, Bernd Gerber et autres

de (code pays fourni par la source)

Meetings and Conferences

Toralf Reimer, Steffi Hartmann, Angrit Stachs, Bernd Gerber et autres

Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer

Bala Başak Öven Ustaalıoğlu, Ahmet Erkan Bilici, Nagehan Özdemir Barışık, Mehmet Aliustaoğlu et autres

tr (code pays fourni par la source)